Bioactivity:

Cgp 6809 is a new methylnitrosoureido-sugar derivative that has been shown to be active against a broad spectrum of transplantable tumours in mice and rats. CGP 6809 is a promising new agent for clinical trials, especially for large bowel and epidermoid l

CAS nr:

84069-38-5

Purity:

98%

Molecular Weight:

321,33

SMILES:

O([C@@H]([C@@H]1[C@H](OC)[C@@H](O)[C@H](O1)OCC)CNC(N(N=O)C)=O)C

Formula:

C12H23N3O7

Pathway:

Target: